Out-licensing drugs to multinational corporations is a natural step for Chinese biotechs, but the recent rise in deals is ...

Global stock markets and U.S. stock futures rose after a slightly lower close on Wall Street on Tuesday, while the U.S. dollar remained under pressure as expectations build for a potential Federal ...

These 10 stocks could mint the next wave of millionaires › IDEAYA Biosciences (NASDAQ:IDYA), a precision oncology company focused on developing targeted therapies for cancer, reported its ...

Shares of Shenzhen-based AI-powered drug researcher XTalPi jumped as much as 23 per cent after it signed a US$6 billion deal ...

Enterprises can use a powerful, near topline OpenAI LLM on their hardware totally privately and securely, without sending data to the cloud.

A thing takes place, and it goes into the history books. But whether something even gets remembered and how is often far from ...

The global Topical Drug Delivery Market, valued at US$247.3 billion in 2024 stood at US$268.4 billion in 2025 and is ...

RIPK1 Inhibitor Emerging therapies such as - SAR443122, GFH312, R552, and others are expected to have a significant impact on ...

Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President ...